Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Taylor

Showing results (301-310 of 335) with videos related to

Pageof 34
Sort By:
The Lancet. Global Health|December 20, 2024
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in UgandaEve Nakabembe, Melanie Greenland, Kyle Amaral, et al.
Pathogens (Basel, Switzerland)|October 27, 2022
Changes in Group B <i>Streptococcus</i> Colonization among Pregnant Women before and after the Onset of the COVID-19 Pandemic in BrazilNatália Silva Costa, André Rio-Tinto, Isabella Bittencourt Ferreira Pinto, et al.
Nature Immunology|March 6, 2021
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.
Nature Immunology|May 21, 2021
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.
JCI Insight|April 14, 2017
M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenzaSuzanne L Cole, Jake Dunning, Wai Ling Kok, et al.
Cell|October 30, 2010
ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent mannerMartin J Law, Karen M Lower, Hsiao P J Voon, et al.
Trials|March 26, 2016
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxisDavid I Dolling, Monica Desai, Alan McOwan, et al.
Ebiomedicine|July 2, 2022
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and femalesNatalie Gabrielle Marchevsky, Grace Li, Parvinder Aley, et al.
Molecular Cell|January 24, 2012
Intragenic enhancers act as alternative promotersMonika S Kowalczyk, Jim R Hughes, David Garrick, et al.
Frontiers in Oncology|November 12, 2019
A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of CancerXi Li, Rouzheng Wang, Peiwen Fan, et al.
Pageof 34

Showing results (301-310 of 335) with videos related to

Sort By:
Pageof 34
The Lancet. Global Health|December 20, 2024
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in UgandaEve Nakabembe, Melanie Greenland, Kyle Amaral, et al.
Pathogens (Basel, Switzerland)|October 27, 2022
Changes in Group B <i>Streptococcus</i> Colonization among Pregnant Women before and after the Onset of the COVID-19 Pandemic in BrazilNatália Silva Costa, André Rio-Tinto, Isabella Bittencourt Ferreira Pinto, et al.
Nature Immunology|March 6, 2021
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.
Nature Immunology|May 21, 2021
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.
JCI Insight|April 14, 2017
M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenzaSuzanne L Cole, Jake Dunning, Wai Ling Kok, et al.
Cell|October 30, 2010
ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent mannerMartin J Law, Karen M Lower, Hsiao P J Voon, et al.
Trials|March 26, 2016
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxisDavid I Dolling, Monica Desai, Alan McOwan, et al.
Ebiomedicine|July 2, 2022
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and femalesNatalie Gabrielle Marchevsky, Grace Li, Parvinder Aley, et al.
Molecular Cell|January 24, 2012
Intragenic enhancers act as alternative promotersMonika S Kowalczyk, Jim R Hughes, David Garrick, et al.
Frontiers in Oncology|November 12, 2019
A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of CancerXi Li, Rouzheng Wang, Peiwen Fan, et al.
Pageof 34